[
  {
    "ts": null,
    "headline": "After Skyrocketing, Energy Drink Maker Celsius Near Buy Point. But Earnings Loom.",
    "summary": "Celsius stock hit its latest buy point before retreating. And third-quarter earnings results are due out in early November.",
    "url": "https://finnhub.io/api/news?id=41f59e1f8c2bc472ea8211bd608b8ba144fe26743b3f63c62919e6d81bcd7985",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761944225,
      "headline": "After Skyrocketing, Energy Drink Maker Celsius Near Buy Point. But Earnings Loom.",
      "id": 137294691,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MNST",
      "source": "Yahoo",
      "summary": "Celsius stock hit its latest buy point before retreating. And third-quarter earnings results are due out in early November.",
      "url": "https://finnhub.io/api/news?id=41f59e1f8c2bc472ea8211bd608b8ba144fe26743b3f63c62919e6d81bcd7985"
    }
  },
  {
    "ts": null,
    "headline": "Monster Beverage Expected to Deliver 'Strong' Q3 Growth, UBS Says",
    "summary": "Monster Beverage (MNST) is expected to deliver another quarter of \"strong\" top-line growth, with UBS",
    "url": "https://finnhub.io/api/news?id=36c7e023827f40a08d2bf1ca8b3dfa35a61e76e590cc4db209df5c65ef9e6e79",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761937935,
      "headline": "Monster Beverage Expected to Deliver 'Strong' Q3 Growth, UBS Says",
      "id": 137295106,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MNST",
      "source": "Yahoo",
      "summary": "Monster Beverage (MNST) is expected to deliver another quarter of \"strong\" top-line growth, with UBS",
      "url": "https://finnhub.io/api/news?id=36c7e023827f40a08d2bf1ca8b3dfa35a61e76e590cc4db209df5c65ef9e6e79"
    }
  },
  {
    "ts": null,
    "headline": "Why AbbVie (ABBV) Shares Are Falling Today",
    "summary": "Shares of pharmaceutical company AbbVie (NYSE:ABBV) fell 3.9% in the afternoon session after the company reported third-quarter results that were overshadowed by a steep drop in profitability and a reduced earnings forecast for the full year. Although AbbVie's quarterly revenue of $15.78 billion and adjusted earnings per share (EPS) of $1.86 both surpassed Wall Street's estimates, investors focused on underlying weaknesses. The company's operating margin fell sharply to 12.1% from 26.5% a year a",
    "url": "https://finnhub.io/api/news?id=fc47f09e219cbaf9e6fd5a1ce6f97091220bb58c93778a59552af34e50794d9e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761930144,
      "headline": "Why AbbVie (ABBV) Shares Are Falling Today",
      "id": 137278863,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MNST",
      "source": "Yahoo",
      "summary": "Shares of pharmaceutical company AbbVie (NYSE:ABBV) fell 3.9% in the afternoon session after the company reported third-quarter results that were overshadowed by a steep drop in profitability and a reduced earnings forecast for the full year. Although AbbVie's quarterly revenue of $15.78 billion and adjusted earnings per share (EPS) of $1.86 both surpassed Wall Street's estimates, investors focused on underlying weaknesses. The company's operating margin fell sharply to 12.1% from 26.5% a year a",
      "url": "https://finnhub.io/api/news?id=fc47f09e219cbaf9e6fd5a1ce6f97091220bb58c93778a59552af34e50794d9e"
    }
  },
  {
    "ts": null,
    "headline": "After More Than Tripling, Energy Drink Maker Celsius Hits Latest Buy Point. But Earnings Loom.",
    "summary": "Celsius stock hit its latest buy point before retreating. And third-quarter earnings results are due out in early November.",
    "url": "https://finnhub.io/api/news?id=55e22b81753049c2ca624b1ec8584cc4519e352400a7775aaaa592a0c7680f57",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761912032,
      "headline": "After More Than Tripling, Energy Drink Maker Celsius Hits Latest Buy Point. But Earnings Loom.",
      "id": 137277363,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MNST",
      "source": "Yahoo",
      "summary": "Celsius stock hit its latest buy point before retreating. And third-quarter earnings results are due out in early November.",
      "url": "https://finnhub.io/api/news?id=55e22b81753049c2ca624b1ec8584cc4519e352400a7775aaaa592a0c7680f57"
    }
  },
  {
    "ts": null,
    "headline": "Monster (MNST): Buy, Sell, or Hold Post Q2 Earnings?",
    "summary": "Even though Monster (currently trading at $65.28 per share) has gained 8.6% over the last six months, it has lagged the S&P 500’s 22.6% return during that period. This might have investors contemplating their next move.",
    "url": "https://finnhub.io/api/news?id=d7acc3dc067d2a18d5cbde9e3d6b22d7aeed27c287fba0cdf0de6725abfa3687",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761883286,
      "headline": "Monster (MNST): Buy, Sell, or Hold Post Q2 Earnings?",
      "id": 137275312,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MNST",
      "source": "Yahoo",
      "summary": "Even though Monster (currently trading at $65.28 per share) has gained 8.6% over the last six months, it has lagged the S&P 500’s 22.6% return during that period. This might have investors contemplating their next move.",
      "url": "https://finnhub.io/api/news?id=d7acc3dc067d2a18d5cbde9e3d6b22d7aeed27c287fba0cdf0de6725abfa3687"
    }
  }
]